MKI67 and central nervous system cancer: Figure 1 demonstrates the commonly used contrast-enhanced T1-weighted MRI scans of different representative glioma entities (WHO grade II and WHO grade IV), the calculated ADC histogram of the respective tumor, as well as the corresponding histopathological images, consisting of HE staining and Ki-67 immunolabeling.